News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuon Therapeutics Inc. Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer


7/16/2009 9:20:18 AM

SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a clinical stage, privately-held biopharmaceutical company focused on novel therapies for autoimmune and inflammatory diseases, today announced the appointments of Paulette Dillon to the position of chief business officer and Tito Serafini, Ph.D., to the position of chief scientific officer, both reporting to president and CEO Rodney Pearlman, Ph.D.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES